These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24228484)

  • 41. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental arrhythmia and its prevention].
    Stazhadze LL; Ventslavskaia TA; Korzhova VV
    Kosm Biol Aviakosm Med; 1985; 19(6):64-8. PubMed ID: 4087865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of substituted N-(4-piperidyl)-N-(3-pyridyl)amides with antiarrhythmic activity. Note 1.
    Pau A; Asproni B; Boatto G; Palomba M; Cerri R; Rimoli MG; Filippelli W; Falcone G
    Pharmazie; 2000 Dec; 55(12):892-5. PubMed ID: 11189863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers.
    Yang W; Wang W; Cai S; Li P; Zhang D; Ning J; Ke J; Hou A; Chen L; Ma Y; Jin W
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vaughan Williams class IV antiarrhythmic drugs].
    Horie M; Washizuka T; Ikeguchi S; Sasayama S
    Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.
    Kieć-Kononowicz K; Byrtus H; Zejc A; Filipek B; Chevallet P
    Farmaco; 1995 May; 50(5):355-60. PubMed ID: 7626171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
    Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anti-arrhythmic action of N-(aminoalkylene) derivatives of indoline-2,3-diones and 1,2-benzene-dicarboxiamides].
    Stankeviciene LM; Raiziene D; Vyzas V; Janusiene L
    Medicina (Kaunas); 2002; 38(3):312-5. PubMed ID: 12474704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Activation of the sympathetic nervous system influences the antifibrillatory effect of class I antiarrhythmic drugs].
    Kaverina NV; Chichkanov GG; Tsorin IB; Kirsanova GIu
    Eksp Klin Farmakol; 2004; 67(5):17-8. PubMed ID: 15559629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The experimental anti-arrhythmia properties of the histamine H1 receptor blockader fencarol].
    Iakovlev GM; Skorobogatov VI; Svistov AS; Mironova MI
    Farmakol Toksikol; 1991; 54(5):25-7. PubMed ID: 1686869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tertiary and quaternary derivatives of aminomethylenedioxyindenes on some experimental arrhythmias.
    Lynch JJ; Rahwan RG; Brumbaugh RJ; Witiak DT
    Can J Physiol Pharmacol; 1982 Dec; 60(12):1636-42. PubMed ID: 7165859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effectiveness of trapidil and trapidil derivatives on drug-induced heart arrhythmias in the rat and guinea pig].
    Riedel A; Schneider S; Mest HJ
    Arzneimittelforschung; 1987 Aug; 37(8):923-6. PubMed ID: 3675688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
    Savina MD
    Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of sodium salicylate and phenobarbital on the anti-arrhythmia properties of novocainamide and acetylnovocainamide].
    Beregovaia EG; Gorchakova NA; Dunaev VV; Chekman IS
    Eksp Klin Farmakol; 1992; 55(5):30-3. PubMed ID: 1284816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.